Northwest Biotherapeutics | NWBO - Activos Circulantes





Activos Circulantes Cambio Fecha
Agenus USD 78.81M 16.47M 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Celldex Therapeutics USD 663.74M 61.2M 2026-09
Eisai JPY 883.01B 121.38B 2026-06
Merck USD 38.94B 2.26B 2026-09
Northwest Biotherapeutics USD 6.2M 996K 2026-03
Pfizer USD 45.01B 3.65B 2026-09
Plus Therapeutics USD 11.77M 6.26M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06